(Q39734181)

English

Assessment of an RNA interference screen-derived mitotic and ceramide pathway metagene as a predictor of response to neoadjuvant paclitaxel for primary triple-negative breast cancer: a retrospective analysis of five clinical trials

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

14 September 2017

Assessment of an RNA interference screen-derived mitotic and ceramide pathway metagene as a predictor of response to neoadjuvant paclitaxel for primary triple-negative breast cancer: a retrospective analysis of five clinical trials (English)

1 reference

Europe PubMed Central

14 September 2017

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

triple-negative breast cancer

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

RNA interference

1 reference

based on heuristic

inferred from title

Zoltan Szallasi

2

1 reference

Europe PubMed Central

14 September 2017

Aron Charles Eklund

3

1 reference

Europe PubMed Central

14 September 2017

Marco Gerlinger

6

1 reference

Europe PubMed Central

14 September 2017

Christine Desmedt

11

1 reference

Europe PubMed Central

14 September 2017

Benjamin Haibe-Kains

12

1 reference

Europe PubMed Central

14 September 2017

Nicolai Juul Birkbak

object named as

Nicolai Juul

1

0 references

Charles Swanton

object named as

Charles Swanton

15

0 references

Francisco J Esteva

object named as

Francisco J Esteva

9

0 references

Christos Sotiriou

13

object named as

Christos Sotiriou

1 reference

Europe PubMed Central

14 September 2017

William Symmans

10

object named as

W Fraser Symmans

1 reference

Europe PubMed Central

14 September 2017

14

object named as

Lajos Pusztai

1 reference

Europe PubMed Central

14 September 2017

María Valero de Vicente

7

object named as

Vicente Valero

1 reference

Europe PubMed Central

14 September 2017

Rebecca Burrell

5

object named as

Rebecca A Burrell

1 reference

Europe PubMed Central

14 September 2017

author name string

Qiyuan Li

4

1 reference

Europe PubMed Central

14 September 2017

Eleni Andreopoulou

8

1 reference

Europe PubMed Central

14 September 2017

publication date

26 February 2010

1 reference

Europe PubMed Central

14 September 2017

Lancet Oncology Commission

1 reference

Europe PubMed Central

14 September 2017

11

1 reference

Europe PubMed Central

14 September 2017

358-365

1 reference

Europe PubMed Central

14 September 2017

4

1 reference

Europe PubMed Central

14 September 2017

Preoperative therapy in invasive breast cancer: pathologic assessment and systemic therapy issues in operable disease

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2810%2970018-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Response to neoadjuvant therapy and long-term survival in patients with triple-negative breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2810%2970018-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Breast cancer molecular subtypes respond differently to preoperative chemotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2810%2970018-8

7 January 2021

based on heuristic

inferred from DOI database lookup

The triple negative paradox: primary tumor chemosensitivity of breast cancer subtypes

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2810%2970018-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Prediction of cancer outcome with microarrays: a multiple random validation strategy

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2810%2970018-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Thousands of samples are needed to generate a robust gene list for predicting outcome in cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2810%2970018-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Validation of gene signatures that predict the response of breast cancer to neoadjuvant chemotherapy: a substudy of the EORTC 10994/BIG 00-01 clinical trial

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2810%2970018-8

7 January 2021

based on heuristic

inferred from DOI database lookup

A stroma-related gene signature predicts resistance to neoadjuvant chemotherapy in breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2810%2970018-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Regulators of mitotic arrest and ceramide metabolism are determinants of sensitivity to paclitaxel and other chemotherapeutic drugs.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2810%2970018-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Ceramide glycosylation potentiates cellular multidrug resistance

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2810%2970018-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Glucosylceramide synthase blockade down-regulates P-glycoprotein and resensitizes multidrug-resistant breast cancer cells to anticancer drugs

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2810%2970018-8

7 January 2021

based on heuristic

inferred from DOI database lookup

RNAi-mediated functional analysis of pathways influencing cancer cell drug resistance.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2810%2970018-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Forensic genetics and ethical, legal and social implications beyond the clinic

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2810%2970018-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Pharmacogenomic predictor of sensitivity to preoperative chemotherapy with paclitaxel and fluorouracil, doxorubicin, and cyclophosphamide in breast cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2810%2970018-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Efficacy of neoadjuvant Cisplatin in triple-negative breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2810%2970018-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Strong time dependence of the 76-gene prognostic signature for node-negative breast cancer patients in the TRANSBIG multicenter independent validation series

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2810%2970018-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Gene expression profiling spares early breast cancer patients from adjuvant therapy: derived and validated in two population-based cohorts

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2810%2970018-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Genomic and transcriptional aberrations linked to breast cancer pathophysiologies

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2810%2970018-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Genomic grade index is associated with response to chemotherapy in patients with breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2810%2970018-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Chromosomal instability determines taxane response

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2810%2970018-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Hallmarks of 'BRCAness' in sporadic cancers

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2810%2970018-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Total RNA yield and microarray gene expression profiles from fine-needle aspiration biopsy and core-needle biopsy samples of breast carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2810%2970018-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Preclinical pharmacology of the taxanes: implications of the differences.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2810%2970018-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Efficacy of weekly paclitaxel in patients with docetaxel-resistant metastatic breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2810%2970018-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Paclitaxel administered weekly in patients with docetaxel-resistant metastatic breast cancer: a single-center study.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2810%2970018-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Uncoupling ceramide glycosylation by transfection of glucosylceramide synthase antisense reverses adriamycin resistance

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2810%2970018-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S1470-2045(10)70018-8

1 reference

Europe PubMed Central

14 September 2017

1 reference

Europe PubMed Central

14 September 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q39734181&oldid=2089207155"